β-Nicotinamide mononucleotide (Synonyms: 烟酰胺单核苷酸; β-NM; NMN)
目录号: PC65651 纯度: ≥99%
CAS No. :1094-61-7
商品编号 规格 价格 会员价 是否有货 数量
PC65651-1mg 1mg 询价 询价
PC65651-10mg 10mg ¥475.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
β-Nicotinamide mononucleotide
中文别名
Β-烟酰胺单核苷酸;烟酰胺核苷酸(Beta-NMN);[(2R,3S,4R,5R)-5-(3-氨基甲酰吡啶-1-鎓-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯;beta-烟酰胺单核苷酸;NMN(β-烟酰胺单核苷酸) I 级;NMN(β-烟酰胺单核苷酸)I级;β-烟酰胺单核苷酸[合成];曲司氯铵;烟酰胺单核苷酸;烟酰胺核苷酸;烟酰胺核苷酸(β-NMN);医药中间体;β-烟酰胺核糖单磷酸盐;A-烟酰胺单核苷酸;Β-烟酰胺单核苷酸(Β-NMN);Β-烟酰胺单核苷酸(烟酰胺核苷酸);NMN(Β-烟酰胺单核苷酸;β-烟酰胺单核苷酸(NMN);β-烟酰胺单核苷酸-烟酰胺单核苷酸;烟酰胺核苷酸 NMN;烟酰胺核苷酸 (NMN)
英文名称
β-Nicotinamide mononucleotide
英文别名
Pyridinium,3-(aminocarbonyl)-1-(5-O-phosphono-b-D-ribofuranosyl)-, inner salt;beta-Nicotinamide Mononucleotide;NMN;β-nicotinamide D-ribonucleotide;β-Nicotinamide Monon;β-Nicotinamide Mononucleotide;β-NM;β-NMN;Nicotinamide ribotide;3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium;3-carbamoyl-1-(5-O-phosphonopentofuranosyl)pyridinium;3-carbamoyl-1-[5-O-(hydroxyphosphinato)-beta-D-ribofuranosyl]pyridinium;Nicotinamide mononucleotide;Pyridinium, 3-(aminocarbonyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)-, inner salt;β-Nicotinamide ribose monophosphate;Nicotinamide-1-ium-1-β-D-ribofuranoside 5′-phosphate;Nicotinamide ribonucleoside 5'-phosphate;Nicotinamide ribonucleotide;beta-D-NMN;beta-NMN;β-D-NMN;NMN zwitterion;Nicotinamide nucleotide;Nicotimide mononucleotide;Nicotinamide mononuclotide;1-[5-O-(Hydroxyphosphinato)pentofuranosyl]pyridin-1-ium-3-carboximidate;1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-[[hydroxy(oxido)phosphoryl]oxymethyl]oxolan-2-yl]pyridin-1-ium-3-ca;CID 138396994;β-NicotinamideMononucleotide;β-Nicotinamide Mononucleotide ,NMN;beta-nicotinamide D-ribonucleotide;nicotinamide D-ribonucleotide;beta-Nicotinamide ribonucleotide;2KG6QX4W0V;((2R,3S,4R,5R)-5-(3-Carbamoylpyridin-1-ium-1-yl)-3,4-d;β-Nicotinamide Mononucleotide(NMN)
Cas No.
1094-61-7
分子式
C11H15N2O8P
分子量
334.22
包装储存
4°C, Keep In Dark;*In solvent : -80°C, 6 months; -20°C, 1 month (Keep In Dark);
生物活性
β-nicotinamide mononucleotide (β-NM) is a product of the nicotinamide phosphoribosyltransferase (NAMPT) reaction and a key NAD intermediate. The pharmacological activities of β-nicotinamide mononucleotide include its role in cellular biochemical functions, cardioprotection, diabetes, Alzheimers disease, and complications associated with obesity.
性状
Solid
IC50 & Target[1][2]
Human Endogenous Metabolite
 
体外研究(In Vitro)
β-nicotinamide mononucleotide has several beneficial pharmacological activities. Mostly mediated by its involvement in NAD biosynthesis, the pharmacological activities of NMN include its role in cellular biochemical functions, cardioprotection, diabetes, Alzheimers disease, and complications associated with obesity.
The intracellular NAD levels are significantly decreased by knockdown or knockout of Nampt (Nampt KD or Nampt KO) or treatment with Nampt inhibitor FK866, whereas NAD levels are dramatically increased by supplement of NAD precursors NAM or NMN (0.5-1 mM). NAD precursor NMN treatment inhibited CD8 T cells activation and function.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
β-Nicotinamide mononucleotide(500 mg/kg; i.p.; 3 times per week for 7-10 week) prevents mtDNA damage and Dox-induced cardiac dysfunction.
Nampt KO markedly inhibits tumor progression, whereas Nampt metabolite β-Nicotinamide mononucleotide (300 mg/kg body weight; i.p.; once every two days for 2 weeks) significantly promotes tumor growth in C57BL/6 mice (bearing wildtype Hepa1-6 cells). The reduction and increase in NAD level of respective Nampt KO and β-Nicotinamide mononucleotide-treated tumors are confirmed.
β-nicotinamide mononucleotide ameliorates glucose intolerance by restoring NAD levels in HFD-induced T2D mice. β-nicotinamide mononucleotide also enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation.
运输条件
Room temperature or refrigerated transport.
储存方式
4°C, Keep In Dark;*In solvent : -80°C, 6 months; -20°C, 1 month (Keep In Dark);
结构分类
Ketones, Aldehydes, Acids
溶解度数据
体外研究:
H2O : 83.33 mg/mL(249.33 mM;Need ultrasonic)
配制储存液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2